Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for Metabolic Syndrome in HIV
NCT04860063Phase 3Unknown
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Apr 2021
- Primary completion
- Apr 2022
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Hospital Civil de Guadalajara. Primary endpoints: Insulin resistance at 24 weeks and Change from baseline lipid profile at 24 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT04860063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04860063.